ReP USP - Resultado da busca

Artigo de periodico
Smoking induces increased apoptosis in osteoblasts: changes in bone matrix organic components (2023)
Kohler, Julia Benini; Silva, Alex Ferreira da; Farias, Walleson Alves; Sampaio, Barbara Fialho Carvalho; Neves, Marco Aurelio Silveiro; Lima, Leandro Gregorut; Lourenco, Juliana Dias; Moreira, Alyne Riani; Tiberio, Iolanda de Fatima Lopes Calvo ; Teodoro, Walcy Rosolia
Source: Scientific reports. Unidade: FM
Subjects: ESTRESSE OXIDATIVO, APOPTOSE, FUMANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KOHLER, Julia Benini et al. Smoking induces increased apoptosis in osteoblasts: changes in bone matrix organic components. Scientific reports, v. 13, n. 1, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54606. Acesso em: 09 nov. 2024.
APA
Kohler, J. B., Silva, A. F. da, Farias, W. A., Sampaio, B. F. C., Neves, M. A. S., Lima, L. G., et al. (2023). Smoking induces increased apoptosis in osteoblasts: changes in bone matrix organic components. Scientific reports, 13( 1). doi:10.1038/s41598-023-33965-8
NLM
Kohler JB, Silva AF da, Farias WA, Sampaio BFC, Neves MAS, Lima LG, Lourenco JD, Moreira AR, Tiberio I de FLC, Teodoro WR. Smoking induces increased apoptosis in osteoblasts: changes in bone matrix organic components [Internet]. Scientific reports. 2023 ; 13( 1):[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54606
Vancouver
Kohler JB, Silva AF da, Farias WA, Sampaio BFC, Neves MAS, Lima LG, Lourenco JD, Moreira AR, Tiberio I de FLC, Teodoro WR. Smoking induces increased apoptosis in osteoblasts: changes in bone matrix organic components [Internet]. Scientific reports. 2023 ; 13( 1):[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54606
Artigo de periodico
The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells (2023)
Lima, Keli ; Miranda, Lívia Bassani Lins De ; Garnique, Anali Del Milagro Bernabe ; Almeida, Bruna Oliveira de ; Nascimento, Mariane Cristina do; Alcântara, Guilherme Augusto Sousa; Machado-Santelli, Glaucia Maria ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Cancers. Unidades: ICB, FM
Subjects: BIOLOGIA CELULAR, FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS PANCREÁTICAS, INIBIDORES DE ENZIMAS, ANTINEOPLÁSICOS, DANO AO DNA, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli et al. The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells. Cancers, v. 15, n. 15, p. 14 , 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15153866. Acesso em: 09 nov. 2024.
APA
Lima, K., Miranda, L. B. L. D., Garnique, A. D. M. B., Almeida, B. O. de, Nascimento, M. C. do, Alcântara, G. A. S., et al. (2023). The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells. Cancers, 15( 15), 14 . doi:10.3390/cancers15153866
NLM
Lima K, Miranda LBLD, Garnique ADMB, Almeida BO de, Nascimento MC do, Alcântara GAS, Machado-Santelli GM, Rego EM, Machado Neto JA. The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells [Internet]. Cancers. 2023 ; 15( 15): 14 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.3390/cancers15153866
Vancouver
Lima K, Miranda LBLD, Garnique ADMB, Almeida BO de, Nascimento MC do, Alcântara GAS, Machado-Santelli GM, Rego EM, Machado Neto JA. The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells [Internet]. Cancers. 2023 ; 15( 15): 14 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.3390/cancers15153866
Artigo de periodico
Administration of a single dose of lithium ameliorates rhabdomyolysis-associated acute kidney injury in rats (2023)
Shimizu, Maria Heloisa Massola ; Volpini, Rildo Aparecido; Braganca, Ana Carolina de; Nascimento, Mariana Moura; Bernardo, Desiree Rita Denelle; Seguro, Antonio Carlos; Cavicchioli, Daniele Canale
Source: Plos one. Unidade: FM
Subjects: MODELOS ANIMAIS, RATOS, INSUFICIÊNCIA RENAL CRÔNICA, APOPTOSE, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SHIMIZU, Maria Heloisa Massola et al. Administration of a single dose of lithium ameliorates rhabdomyolysis-associated acute kidney injury in rats. Plos one, v. 18, n. 2, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/56317. Acesso em: 09 nov. 2024.
APA
Shimizu, M. H. M., Volpini, R. A., Braganca, A. C. de, Nascimento, M. M., Bernardo, D. R. D., Seguro, A. C., & Cavicchioli, D. C. (2023). Administration of a single dose of lithium ameliorates rhabdomyolysis-associated acute kidney injury in rats. Plos one, 18( 2). doi:10.1371/journal.pone.0281679
NLM
Shimizu MHM, Volpini RA, Braganca AC de, Nascimento MM, Bernardo DRD, Seguro AC, Cavicchioli DC. Administration of a single dose of lithium ameliorates rhabdomyolysis-associated acute kidney injury in rats [Internet]. Plos one. 2023 ; 18( 2):[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56317
Vancouver
Shimizu MHM, Volpini RA, Braganca AC de, Nascimento MM, Bernardo DRD, Seguro AC, Cavicchioli DC. Administration of a single dose of lithium ameliorates rhabdomyolysis-associated acute kidney injury in rats [Internet]. Plos one. 2023 ; 18( 2):[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56317
Artigo de periodico
Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models (2023)
Nascimento, Mariane Cristina do ; Martins, Diego Antonio Pereira ; Alcântara, Guilherme Augusto Sousa; Lima, Keli Cristina de ; Vicari, Hugo Passos ; Huls, Gerwin A. ; Schuringa, Jan Jacob ; Rego, Eduardo Magalhães ; Ferreira, Marcelo José Pena ; Costa-Lotufo, Letícia Veras ; Machado Neto, João Agostinho
Source: Blood. Conference titles: 65th ASH Annual Meeting Abstracts. Unidades: IB, FM, ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, HEMATOLOGIA, QUIMIOTERAPIA COMBINADA, CÉLULAS CULTIVADAS DE TUMOR, PROLIFERAÇÃO CELULAR, NEOPLASIAS POR TIPO HISTOLÓGICO, APOPTOSE, DANO AO DNA, MITOCÔNDRIAS, PROTEÔMICA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Mariane Cristina do et al. Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models. Blood, v. 142, n. res. 604, p. 5751, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood-2023-189814. Acesso em: 09 nov. 2024.
APA
Nascimento, M. C. do, Martins, D. A. P., Alcântara, G. A. S., Lima, K. C. de, Vicari, H. P., Huls, G. A., et al. (2023). Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models. Blood, 142( res. 604), 5751. doi:10.1182/blood-2023-189814
NLM
Nascimento MC do, Martins DAP, Alcântara GAS, Lima KC de, Vicari HP, Huls GA, Schuringa JJ, Rego EM, Ferreira MJP, Costa-Lotufo LV, Machado Neto JA. Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models [Internet]. Blood. 2023 ; 142( res. 604): 5751.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1182/blood-2023-189814
Vancouver
Nascimento MC do, Martins DAP, Alcântara GAS, Lima KC de, Vicari HP, Huls GA, Schuringa JJ, Rego EM, Ferreira MJP, Costa-Lotufo LV, Machado Neto JA. Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models [Internet]. Blood. 2023 ; 142( res. 604): 5751.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1182/blood-2023-189814
Artigo de periodico
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study (2023)
Haverkos, Bradley; Alpdogan, Onder; Baiocchi, Robert; Brammer, Jonathan E; Feldman, Tatyana A; Capra, Marcelo; Brem, Elizabeth A; Nair, Santosh; Scheinberg, Phillip; Pereira, Juliana
Source: Blood advances. Unidade: FM
Subjects: LINFOMA, INFECÇÕES POR VÍRUS DE DNA, INIBIDORES DE ENZIMAS, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HAVERKOS, Bradley et al. Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study. Blood advances, v. 7, n. 20, p. 6339-6350, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57344. Acesso em: 09 nov. 2024.
APA
Haverkos, B., Alpdogan, O., Baiocchi, R., Brammer, J. E., Feldman, T. A., Capra, M., et al. (2023). Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study. Blood advances, 7( 20), 6339-6350. doi:10.1182/bloodadvances.2023010330
NLM
Haverkos B, Alpdogan O, Baiocchi R, Brammer JE, Feldman TA, Capra M, Brem EA, Nair S, Scheinberg P, Pereira J. Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study [Internet]. Blood advances. 2023 ; 7( 20): 6339-6350.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57344
Vancouver
Haverkos B, Alpdogan O, Baiocchi R, Brammer JE, Feldman TA, Capra M, Brem EA, Nair S, Scheinberg P, Pereira J. Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study [Internet]. Blood advances. 2023 ; 7( 20): 6339-6350.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57344
Artigo de periodico
Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia (2023)
Lima, Keli Cristina de ; Carvalho, Maria Fernanda Lopes ; Pereira-Martins, Diego Antonio ; Nogueira, Frederico Lisboa ; Miranda, Lívia Bassani Lins de ; Mariane Cristina do Nascimento ; Cavaglieri, Rita de Cássia ; Schuringa, Jan Jacob ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: International Journal of Molecular Sciences. Unidades: FM, ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, NEOPLASIAS POR TIPO HISTOLÓGICO, ANTINEOPLÁSICOS, APOPTOSE, PROTEÍNAS PROTO-ONCOGÊNICAS, COMPOSTOS HETEROCÍCLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia. International Journal of Molecular Sciences, v. 24, n. 23, p. 12 , 2023Tradução . . Disponível em: https://doi.org/10.3390/ijms242316899. Acesso em: 09 nov. 2024.
APA
Lima, K. C. de, Carvalho, M. F. L., Pereira-Martins, D. A., Nogueira, F. L., Miranda, L. B. L. de, Mariane Cristina do Nascimento,, et al. (2023). Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia. International Journal of Molecular Sciences, 24( 23), 12 . doi:10.3390/ijms242316899
NLM
Lima KC de, Carvalho MFL, Pereira-Martins DA, Nogueira FL, Miranda LBL de, Mariane Cristina do Nascimento, Cavaglieri R de C, Schuringa JJ, Rego EM, Machado Neto JA. Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia [Internet]. International Journal of Molecular Sciences. 2023 ; 24( 23): 12 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.3390/ijms242316899
Vancouver
Lima KC de, Carvalho MFL, Pereira-Martins DA, Nogueira FL, Miranda LBL de, Mariane Cristina do Nascimento, Cavaglieri R de C, Schuringa JJ, Rego EM, Machado Neto JA. Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia [Internet]. International Journal of Molecular Sciences. 2023 ; 24( 23): 12 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.3390/ijms242316899
Artigo de periodico
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy (2022)
Lima, Keli Cristina de ; Martins, Diego Antonio Pereira ; Miranda, Lívia Bassani Lins De ; Silva, Juan Luiz Coelho ; Leandro, Giovana da Silva ; Weinhäuser, Isabel ; Cavaglieri, Rita de Cássia; Leal, Aline de Medeiros; Silva, Wellington Fernandes da; Lange, Ana Paula Alencar de Lima; Velloso, Elvira Deolinda Rodrigues Pereira ; Rego, Eduardo Magalhães ; Griessinger, Emmanuel ; Hilberink, Jacobien R. ; Ammatuna, Emanuele ; Huls, Gerwin ; Schuringa, Jan Jacob ; Machado Neto, João Agostinho
Source: Blood Cancer Journal. Unidades: FM, ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, HOMEOSTASE, APOPTOSE, MITOCÔNDRIAS, ESPECTROMETRIA DE MASSAS, CROMATOGRAFIA LÍQUIDA, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy. Blood Cancer Journal, v. 12, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41408-022-00747-w. Acesso em: 09 nov. 2024.
APA
Lima, K. C. de, Martins, D. A. P., Miranda, L. B. L. D., Silva, J. L. C., Leandro, G. da S., Weinhäuser, I., et al. (2022). The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy. Blood Cancer Journal, 12, 1-11. doi:10.1038/s41408-022-00747-w
NLM
Lima KC de, Martins DAP, Miranda LBLD, Silva JLC, Leandro G da S, Weinhäuser I, Cavaglieri R de C, Leal A de M, Silva WF da, Lange APA de L, Velloso EDRP, Rego EM, Griessinger E, Hilberink JR, Ammatuna E, Huls G, Schuringa JJ, Machado Neto JA. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy [Internet]. Blood Cancer Journal. 2022 ; 12 1-11.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/s41408-022-00747-w
Vancouver
Lima KC de, Martins DAP, Miranda LBLD, Silva JLC, Leandro G da S, Weinhäuser I, Cavaglieri R de C, Leal A de M, Silva WF da, Lange APA de L, Velloso EDRP, Rego EM, Griessinger E, Hilberink JR, Ammatuna E, Huls G, Schuringa JJ, Machado Neto JA. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy [Internet]. Blood Cancer Journal. 2022 ; 12 1-11.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/s41408-022-00747-w
Artigo de periodico
Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells (2022)
Fernandes, Jaqueline Cristina; Fenerich, Bruna Alves ; Silva, Antônio Bruno Alves; Fonseca, Natasha Peixoto ; Silva, Juan Luiz Coelho ; Scheucher, Priscila Santos ; Rego, Eduardo Magalhães ; Pontes, Lorena Lôbo Figueiredo ; Machado Neto, João Agostinho ; Traina, Fabiola
Source: Toxicology in Vitro. Unidades: FM, FMRP, ICB
Subjects: FARMACOLOGIA, ANTINEOPLÁSICOS, INIBIDORES QUÍMICOS, MEDULA ÓSSEA, CÉLULAS-TRONCO, PROLIFERAÇÃO CELULAR, APOPTOSE, MUTAÇÃO, CÉLULAS MIELOIDES, FATORES DE CRESCIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Jaqueline Cristina et al. Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells. Toxicology in Vitro, v. 83, p. 1-7, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.tiv.2022.105384. Acesso em: 09 nov. 2024.
APA
Fernandes, J. C., Fenerich, B. A., Silva, A. B. A., Fonseca, N. P., Silva, J. L. C., Scheucher, P. S., et al. (2022). Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells. Toxicology in Vitro, 83, 1-7. doi:10.1016/j.tiv.2022.105384
NLM
Fernandes JC, Fenerich BA, Silva ABA, Fonseca NP, Silva JLC, Scheucher PS, Rego EM, Pontes LLF, Machado Neto JA, Traina F. Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells [Internet]. Toxicology in Vitro. 2022 ; 83 1-7.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.tiv.2022.105384
Vancouver
Fernandes JC, Fenerich BA, Silva ABA, Fonseca NP, Silva JLC, Scheucher PS, Rego EM, Pontes LLF, Machado Neto JA, Traina F. Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells [Internet]. Toxicology in Vitro. 2022 ; 83 1-7.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.tiv.2022.105384
Artigo de periodico-carta/editorial
Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax (2022)
Lima, Keli Cristina de ; Vicari, Hugo Passos ; Carlos, Jorge Antonio Elias Godoy; Silva, Jean Carlos Lipreri da ; Pontes, Lorena Lobo de Figueiredo ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Hematology, Transfusion and Cell Therapy. Unidades: FMRP, FM, ICB
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, APOPTOSE, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2021.01.004. Acesso em: 09 nov. 2024. , 2022
APA
Lima, K. C. de, Vicari, H. P., Carlos, J. A. E. G., Silva, J. C. L. da, Pontes, L. L. de F., Rego, E. M., & Machado Neto, J. A. (2022). Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax. Hematology, Transfusion and Cell Therapy. São José do Rio Preto: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.htct.2021.01.004
NLM
Lima KC de, Vicari HP, Carlos JAEG, Silva JCL da, Pontes LL de F, Rego EM, Machado Neto JA. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44( 1): 124-127.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.htct.2021.01.004
Vancouver
Lima KC de, Vicari HP, Carlos JAEG, Silva JCL da, Pontes LL de F, Rego EM, Machado Neto JA. Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44( 1): 124-127.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.htct.2021.01.004
Artigo de periodico
Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia (2022)
Silva, Jean Carlos Lipreri da ; Araujo, Felipe Saldanha ; Melo, Raphael Costa Bandeira de; Vicari, Hugo Passos ; Carvalho, Amandda Evelin Silva ; Rego, Eduardo Magalhães ; Buccheri, Valeria ; Machado Neto, João Agostinho
Source: Life Sciences. Unidades: FM, ICB
Subjects: FARMACOLOGIA, DOENÇAS HEMATOLÓGICAS, LEUCEMIA, LINFÓCITOS B, ONCOGENES, CÉLULAS CULTIVADAS DE TUMOR, APOPTOSE, LINFOMA, MEMBRANA PLASMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jean Carlos Lipreri da et al. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia. Life Sciences, v. 311, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2022.121146. Acesso em: 09 nov. 2024.
APA
Silva, J. C. L. da, Araujo, F. S., Melo, R. C. B. de, Vicari, H. P., Carvalho, A. E. S., Rego, E. M., et al. (2022). Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia. Life Sciences, 311, 1-9. doi:10.1016/j.lfs.2022.121146
NLM
Silva JCL da, Araujo FS, Melo RCB de, Vicari HP, Carvalho AES, Rego EM, Buccheri V, Machado Neto JA. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia [Internet]. Life Sciences. 2022 ; 311 1-9.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.lfs.2022.121146
Vancouver
Silva JCL da, Araujo FS, Melo RCB de, Vicari HP, Carvalho AES, Rego EM, Buccheri V, Machado Neto JA. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia [Internet]. Life Sciences. 2022 ; 311 1-9.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.lfs.2022.121146
Artigo de periodico
NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia (2021)
Ribeiro, Renata Scopim ; Machado Neto, João Agostinho ; Eide, Christopher A. ; Silva, Juan Luiz Coelho da ; Fenerich, Bruna Alves ; Fernandes, Jaqueline Cristina; Scheucher, Priscila Santos ; Stevens, Samantha L. Savage ; Campos, Paula de Melo; Saad, Sara T. Olalla ; Palma, Leonardo de Carvalho ; Pontes, Lorena Lobo de Figueiredo ; Simões, Belinda Pinto ; Rego, Eduardo Magalhães ; Tognon, Cristina E. ; Druker, Brian J. ; Traina, Fabiola
Source: Investigational New Drugs. Unidades: ICB, FMRP, FM
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE, INSULINA, ANTINEOPLÁSICOS, PROTEÍNAS QUINASES, CÉLULAS SANGUÍNEAS, PROLIFERAÇÃO CELULAR, APOPTOSE, ONCOGENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Renata Scopim et al. NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia. Investigational New Drugs, v. 39, n. 3, p. 736-746, 2021Tradução . . Disponível em: https://doi.org/10.1007/s10637-020-01028-8. Acesso em: 09 nov. 2024.
APA
Ribeiro, R. S., Machado Neto, J. A., Eide, C. A., Silva, J. L. C. da, Fenerich, B. A., Fernandes, J. C., et al. (2021). NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia. Investigational New Drugs, 39( 3), 736-746. doi:10.1007/s10637-020-01028-8
NLM
Ribeiro RS, Machado Neto JA, Eide CA, Silva JLC da, Fenerich BA, Fernandes JC, Scheucher PS, Stevens SLS, Campos P de M, Saad STO, Palma L de C, Pontes LL de F, Simões BP, Rego EM, Tognon CE, Druker BJ, Traina F. NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia [Internet]. Investigational New Drugs. 2021 ; 39( 3): 736-746.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1007/s10637-020-01028-8
Vancouver
Ribeiro RS, Machado Neto JA, Eide CA, Silva JLC da, Fenerich BA, Fernandes JC, Scheucher PS, Stevens SLS, Campos P de M, Saad STO, Palma L de C, Pontes LL de F, Simões BP, Rego EM, Tognon CE, Druker BJ, Traina F. NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia [Internet]. Investigational New Drugs. 2021 ; 39( 3): 736-746.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1007/s10637-020-01028-8
Artigo de periodico
MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model (2021)
Pereira-Martins, Diego Antonio; Weinhäuser, Isabel; Coelho-Silva, Juan Luiz; Franca-Neto, Pedro L.; Almeida, Luciana Y.; Bianco, Thiago Mantello; Silva, Cleide L.; Franca, Rafael Freitas de Oliveira; Traina, Fabiola; Rego, Eduardo Magalhães; Schuringa, Jan Jacob; Lucena-Araújo, Antonio Roberto
Source: Cell Death & Disease. Unidades: FMRP, FM
Subjects: ANTINEOPLÁSICOS, APOPTOSE, DIFERENCIAÇÃO CELULAR, PROLIFERAÇÃO CELULAR, LEUCEMIA, FATORES DE TRANSCRIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA-MARTINS, Diego Antonio et al. MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model. Cell Death & Disease, v. 12, n. 4, p. 1-14, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41419-021-03604-z. Acesso em: 09 nov. 2024.
APA
Pereira-Martins, D. A., Weinhäuser, I., Coelho-Silva, J. L., Franca-Neto, P. L., Almeida, L. Y., Bianco, T. M., et al. (2021). MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model. Cell Death & Disease, 12( 4), 1-14. doi:10.1038/s41419-021-03604-z
NLM
Pereira-Martins DA, Weinhäuser I, Coelho-Silva JL, Franca-Neto PL, Almeida LY, Bianco TM, Silva CL, Franca RF de O, Traina F, Rego EM, Schuringa JJ, Lucena-Araújo AR. MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model [Internet]. Cell Death & Disease. 2021 ; 12( 4): 1-14.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/s41419-021-03604-z
Vancouver
Pereira-Martins DA, Weinhäuser I, Coelho-Silva JL, Franca-Neto PL, Almeida LY, Bianco TM, Silva CL, Franca RF de O, Traina F, Rego EM, Schuringa JJ, Lucena-Araújo AR. MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model [Internet]. Cell Death & Disease. 2021 ; 12( 4): 1-14.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/s41419-021-03604-z
Artigo de periodico
NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells (2020)
Fenerich, Bruna Alves ; Fernandes, Jaqueline Cristina; Alves, Ana Paula Nunes Rodrigues; Silva, Juan Luiz Coelho da ; Ribeiro, Renata Scopim; Scheucher, Priscila Santos ; Eide, Christopher A.; Tognon, Cristina E.; Druker, Brian J. ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho ; Traina, Fabiola
Source: Signal Transduction and Targeted Therapy. Unidades: FMRP, FM, ICB
Subjects: FARMACOLOGIA, TRANSDUÇÃO DE SINAL CELULAR, CÉLULAS CULTIVADAS DE TUMOR, ANTINEOPLÁSICOS, PROLIFERAÇÃO CELULAR, ERITROPOIETINA, APOPTOSE, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FENERICH, Bruna Alves et al. NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells. Signal Transduction and Targeted Therapy, p. 10 , 2020Tradução . . Disponível em: https://doi.org/10.1038/s41392-019-0102-5. Acesso em: 09 nov. 2024.
APA
Fenerich, B. A., Fernandes, J. C., Alves, A. P. N. R., Silva, J. L. C. da, Ribeiro, R. S., Scheucher, P. S., et al. (2020). NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells. Signal Transduction and Targeted Therapy, 10 . doi:10.1038/s41392-019-0102-5
NLM
Fenerich BA, Fernandes JC, Alves APNR, Silva JLC da, Ribeiro RS, Scheucher PS, Eide CA, Tognon CE, Druker BJ, Rego EM, Machado Neto JA, Traina F. NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells [Internet]. Signal Transduction and Targeted Therapy. 2020 ; 10 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/s41392-019-0102-5
Vancouver
Fenerich BA, Fernandes JC, Alves APNR, Silva JLC da, Ribeiro RS, Scheucher PS, Eide CA, Tognon CE, Druker BJ, Rego EM, Machado Neto JA, Traina F. NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells [Internet]. Signal Transduction and Targeted Therapy. 2020 ; 10 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/s41392-019-0102-5
Artigo de periodico
Bcl-2/Bax ratio increase does not prevent apoptosis of glia and granular neurons in patients with temporal lobe epilepsy (2019)
Toscano, Eliana C. de Brito; Vieira, Erica L. M; Portela, Ana C. D. C; Reis, Joice L. J; Caliari, Marcelo; Giannetti, Alexandre; Goncalves, Ana P; Siqueira, Jose M; Suemoto, Claudia Kimie ; Nitrini, Ricardo
Source: Neuropathology. Unidade: FM
Subjects: APOPTOSE, EPILEPSIA DO LOBO TEMPORAL, NEURÓGLIA, METABOLISMO, PATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOSCANO, Eliana C. de Brito et al. Bcl-2/Bax ratio increase does not prevent apoptosis of glia and granular neurons in patients with temporal lobe epilepsy. Neuropathology, v. 39, n. 5, p. 348-357, 2019Tradução . . Disponível em: https://doi.org/10.1111/neup.12592. Acesso em: 09 nov. 2024.
APA
Toscano, E. C. de B., Vieira, E. L. M., Portela, A. C. D. C., Reis, J. L. J., Caliari, M., Giannetti, A., et al. (2019). Bcl-2/Bax ratio increase does not prevent apoptosis of glia and granular neurons in patients with temporal lobe epilepsy. Neuropathology, 39( 5), 348-357. doi:10.1111/neup.12592
NLM
Toscano EC de B, Vieira ELM, Portela ACDC, Reis JLJ, Caliari M, Giannetti A, Goncalves AP, Siqueira JM, Suemoto CK, Nitrini R. Bcl-2/Bax ratio increase does not prevent apoptosis of glia and granular neurons in patients with temporal lobe epilepsy [Internet]. Neuropathology. 2019 ; 39( 5): 348-357.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1111/neup.12592
Vancouver
Toscano EC de B, Vieira ELM, Portela ACDC, Reis JLJ, Caliari M, Giannetti A, Goncalves AP, Siqueira JM, Suemoto CK, Nitrini R. Bcl-2/Bax ratio increase does not prevent apoptosis of glia and granular neurons in patients with temporal lobe epilepsy [Internet]. Neuropathology. 2019 ; 39( 5): 348-357.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1111/neup.12592
Artigo de periodico
Chemical composition and cytotoxic screening of musa cavendish green peels extract: antiproliferative activity by activation of different cellular death types (2019)
Barroso, Wermerson Assuncao; Abreu, Iracelle Carvalho; Ribeiro, Larissa Sousa; Rocha, Claudia Quintino da; Souza, Heraldo Possolo de; Lima, Thais Martins de
Source: Toxicology in vitro. Unidade: FM
Subjects: BANANA, EXTRATOS (FORMAS FARMACÊUTICAS), CITOTOXICIDADE IMUNOLÓGICA, APOPTOSE, NEOPLASIAS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARROSO, Wermerson Assuncao et al. Chemical composition and cytotoxic screening of musa cavendish green peels extract: antiproliferative activity by activation of different cellular death types. Toxicology in vitro, v. 59, p. 179-186, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.tiv.2019.04.020. Acesso em: 09 nov. 2024.
APA
Barroso, W. A., Abreu, I. C., Ribeiro, L. S., Rocha, C. Q. da, Souza, H. P. de, & Lima, T. M. de. (2019). Chemical composition and cytotoxic screening of musa cavendish green peels extract: antiproliferative activity by activation of different cellular death types. Toxicology in vitro, 59, 179-186. doi:10.1016/j.tiv.2019.04.020
NLM
Barroso WA, Abreu IC, Ribeiro LS, Rocha CQ da, Souza HP de, Lima TM de. Chemical composition and cytotoxic screening of musa cavendish green peels extract: antiproliferative activity by activation of different cellular death types [Internet]. Toxicology in vitro. 2019 ; 59 179-186.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.tiv.2019.04.020
Vancouver
Barroso WA, Abreu IC, Ribeiro LS, Rocha CQ da, Souza HP de, Lima TM de. Chemical composition and cytotoxic screening of musa cavendish green peels extract: antiproliferative activity by activation of different cellular death types [Internet]. Toxicology in vitro. 2019 ; 59 179-186.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.tiv.2019.04.020
Artigo de periodico
IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells (2019)
Alves, Ana Paula Nunes Rodrigues; Fernandes, Jaqueline Cristina; Fenerich, Bruna Alves ; Silva, Juan Luiz Coelho da; Scheucher, Priscila Santos ; Simões, Belinda Pinto ; Rego, Eduardo Magalhaes ; Ridley, Anne J. ; Machado Neto, João Agostinho ; Traina, Fabiola
Source: Cancer Letters. Unidades: FMRP, FM, ICB
Subjects: LEUCEMIA, CÉLULAS SANGUINEAS, CITOTOXINAS, APOPTOSE, CÉLULAS CULTIVADAS DE TUMOR, ONCOGENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Ana Paula Nunes Rodrigues et al. IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells. Cancer Letters, v. 456, p. 59-68, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.canlet.2019.04.030. Acesso em: 09 nov. 2024.
APA
Alves, A. P. N. R., Fernandes, J. C., Fenerich, B. A., Silva, J. L. C. da, Scheucher, P. S., Simões, B. P., et al. (2019). IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells. Cancer Letters, 456, 59-68. doi:10.1016/j.canlet.2019.04.030
NLM
Alves APNR, Fernandes JC, Fenerich BA, Silva JLC da, Scheucher PS, Simões BP, Rego EM, Ridley AJ, Machado Neto JA, Traina F. IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells [Internet]. Cancer Letters. 2019 ; 456 59-68.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.canlet.2019.04.030
Vancouver
Alves APNR, Fernandes JC, Fenerich BA, Silva JLC da, Scheucher PS, Simões BP, Rego EM, Ridley AJ, Machado Neto JA, Traina F. IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells [Internet]. Cancer Letters. 2019 ; 456 59-68.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.canlet.2019.04.030
Artigo de periodico
Hypertonic saline and pentoxifylline enhance survival, reducing apoptosis and oxidative stress in a rat model of strangulated closed loop small bowel obstruction (2019)
Scapini, Gustavo; Rasslan, Roberto; Cayuela, Natalie Chaves; Goes, Miguel Angelo; Koike, Marcia Kiyomi; Utiyama, Edivaldo Massazo; Montero, Edna Frasson de Souza; Rasslan, Samir
Source: Clinics. Unidade: FM
Subjects: APOPTOSE, ESTRESSE OXIDATIVO, ENTEROPATIAS, INTESTINO DELGADO, SOLUÇÕES, AGREGAÇÃO PLAQUETÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCAPINI, Gustavo et al. Hypertonic saline and pentoxifylline enhance survival, reducing apoptosis and oxidative stress in a rat model of strangulated closed loop small bowel obstruction. Clinics, v. 74, 2019Tradução . . Disponível em: https://doi.org/10.6061/clinics/2019/e787. Acesso em: 09 nov. 2024.
APA
Scapini, G., Rasslan, R., Cayuela, N. C., Goes, M. A., Koike, M. K., Utiyama, E. M., et al. (2019). Hypertonic saline and pentoxifylline enhance survival, reducing apoptosis and oxidative stress in a rat model of strangulated closed loop small bowel obstruction. Clinics, 74. doi:10.6061/clinics/2019/e787
NLM
Scapini G, Rasslan R, Cayuela NC, Goes MA, Koike MK, Utiyama EM, Montero EF de S, Rasslan S. Hypertonic saline and pentoxifylline enhance survival, reducing apoptosis and oxidative stress in a rat model of strangulated closed loop small bowel obstruction [Internet]. Clinics. 2019 ; 74[citado 2024 nov. 09 ] Available from: https://doi.org/10.6061/clinics/2019/e787
Vancouver
Scapini G, Rasslan R, Cayuela NC, Goes MA, Koike MK, Utiyama EM, Montero EF de S, Rasslan S. Hypertonic saline and pentoxifylline enhance survival, reducing apoptosis and oxidative stress in a rat model of strangulated closed loop small bowel obstruction [Internet]. Clinics. 2019 ; 74[citado 2024 nov. 09 ] Available from: https://doi.org/10.6061/clinics/2019/e787
Artigo de periodico
TLR2 and TLR4 play opposite role in autophagy associated with cisplatin-induced acute kidney injury (2018)
Andrade-silva, Magaiver; Malheiros, Denise Maria Avancini Costa; Fujihara, Clarice Kazue; Zatz, Roberto
Source: Clinical science. Unidade: FM
Subjects: INSUFICIÊNCIA RENAL AGUDA, RECEPTORES CELULARES, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE-SILVA, Magaiver et al. TLR2 and TLR4 play opposite role in autophagy associated with cisplatin-induced acute kidney injury. Clinical science, v. 132, n. 16, p. 1725-1739, 2018Tradução . . Disponível em: https://doi.org/10.1042/CS20170262. Acesso em: 09 nov. 2024.
APA
Andrade-silva, M., Malheiros, D. M. A. C., Fujihara, C. K., & Zatz, R. (2018). TLR2 and TLR4 play opposite role in autophagy associated with cisplatin-induced acute kidney injury. Clinical science, 132( 16), 1725-1739. doi:10.1042/CS20170262
NLM
Andrade-silva M, Malheiros DMAC, Fujihara CK, Zatz R. TLR2 and TLR4 play opposite role in autophagy associated with cisplatin-induced acute kidney injury [Internet]. Clinical science. 2018 ; 132( 16): 1725-1739.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1042/CS20170262
Vancouver
Andrade-silva M, Malheiros DMAC, Fujihara CK, Zatz R. TLR2 and TLR4 play opposite role in autophagy associated with cisplatin-induced acute kidney injury [Internet]. Clinical science. 2018 ; 132( 16): 1725-1739.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1042/CS20170262
Artigo de periodico
Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms (2018)
Machado Neto, João Agostinho ; Fenerich, Bruna Alves; Ribeiro, Renata Scopim; Eide, Christopher A; Silva, Juan Luiz Coelho da; Dechandt, Carlos Roberto Porto; Fernandes, Jaqueline Cristina; Alves, Ana Paula Nunes Rodrigues; Scheucher, Priscila Santos; Simões, Belinda Pinto; Alberici, Luciane Carla; Pontes, Lorena Lôbo de Figueiredo; Tognon, Cristina E; Druker, Brian J; Rego, Eduardo Magalhães; Traina, Fabíola
Source: Cell Death & Disease. Unidades: ICB, FMRP, FCFRP, FM
Subjects: METFORMINA, PROLIFERAÇÃO CELULAR, APOPTOSE, MUTAÇÃO GENÉTICA, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO NETO, João Agostinho et al. Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms. Cell Death & Disease, v. 9, n. 3, p. 16 , 2018Tradução . . Disponível em: https://doi.org/10.1038/s41419-017-0256-4. Acesso em: 09 nov. 2024.
APA
Machado Neto, J. A., Fenerich, B. A., Ribeiro, R. S., Eide, C. A., Silva, J. L. C. da, Dechandt, C. R. P., et al. (2018). Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms. Cell Death & Disease, 9( 3), 16 . doi:10.1038/s41419-017-0256-4
NLM
Machado Neto JA, Fenerich BA, Ribeiro RS, Eide CA, Silva JLC da, Dechandt CRP, Fernandes JC, Alves APNR, Scheucher PS, Simões BP, Alberici LC, Pontes LL de F, Tognon CE, Druker BJ, Rego EM, Traina F. Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms [Internet]. Cell Death & Disease. 2018 ; 9( 3): 16 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/s41419-017-0256-4
Vancouver
Machado Neto JA, Fenerich BA, Ribeiro RS, Eide CA, Silva JLC da, Dechandt CRP, Fernandes JC, Alves APNR, Scheucher PS, Simões BP, Alberici LC, Pontes LL de F, Tognon CE, Druker BJ, Rego EM, Traina F. Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms [Internet]. Cell Death & Disease. 2018 ; 9( 3): 16 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/s41419-017-0256-4
Artigo de periodico
Oxysterols selectively promote short-term apoptosis in tumor cell lines (2018)
Levy, Debora; Melo, Thatiana Correa de; Ohira, Bianca Yumi; Fidelis, Maira Luisa; Ruiz, Jorge L. M.; Rodrigues, Alessandro; Bydlowski, Sérgio Paulo
Source: Biochemical and biophysical research communications. Unidade: FM
Subjects: APOPTOSE, COLESTEROL, ESTEROIDES, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEVY, Debora et al. Oxysterols selectively promote short-term apoptosis in tumor cell lines. Biochemical and biophysical research communications, v. 505, n. 4, p. 1043-1049, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.bbrc.2018.10.008. Acesso em: 09 nov. 2024.
APA
Levy, D., Melo, T. C. de, Ohira, B. Y., Fidelis, M. L., Ruiz, J. L. M., Rodrigues, A., & Bydlowski, S. P. (2018). Oxysterols selectively promote short-term apoptosis in tumor cell lines. Biochemical and biophysical research communications, 505( 4), 1043-1049. doi:10.1016/j.bbrc.2018.10.008
NLM
Levy D, Melo TC de, Ohira BY, Fidelis ML, Ruiz JLM, Rodrigues A, Bydlowski SP. Oxysterols selectively promote short-term apoptosis in tumor cell lines [Internet]. Biochemical and biophysical research communications. 2018 ; 505( 4): 1043-1049.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.bbrc.2018.10.008
Vancouver
Levy D, Melo TC de, Ohira BY, Fidelis ML, Ruiz JLM, Rodrigues A, Bydlowski SP. Oxysterols selectively promote short-term apoptosis in tumor cell lines [Internet]. Biochemical and biophysical research communications. 2018 ; 505( 4): 1043-1049.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.bbrc.2018.10.008

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation